LivaNova PLC (LIVN)

LivaNova PLC (LIVN) is a healthcare company (medical devices) based in the United Kingdom. The share price is $93.35, up 0.98% on the day, which values the company at $5.14B. Price as of 17 Nov 2026, 17:43 UTC, from Yahoo Finance.

Key facts

Share price
$93.35+0.98% today
Market value
$5.14B
P/E ratio
26.7×last 12 months
Forward P/E
19.7×
Funk Score
59/100
Against its own history
Above its usual priceusual price $79.78
200-week average
$55.7168% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

LivaNova PLC in more detail

LIVN trades at 26.7× its last twelve months' earnings, 19.7× next year's expected earnings, 3.4× sales. Measured against its own history, the price is 17% above what its usual multiples would imply ($79.78) — above its usual price. It sits 68% above its 200-week average of $55.71.

Over the last five fiscal years LivaNova PLC has compounded revenue 8.2% a year. Its Funk Score is 59 out of 100 (financial strength 5.8, profitability 5.7, growth 6.3, value 5.8, each out of 10).

In its favour: More cash than debt; High return on invested capital.

1 of the superinvestors tracked here hold LIVN, including Primecap team (0.2% of the portfolio).

Superinvestors holding LIVN

1 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:LIVN vs IONS (LivaNova PLC vs Ionis Pharmaceuticals)LIVN vs DNTH (LivaNova PLC vs Dianthus Therapeutics)LIVN vs MMED (LivaNova PLC vs MiniMed Group)LIVN vs EWTX (LivaNova PLC vs Edgewise Therapeutics)LIVN vs ADPT (LivaNova PLC vs Adaptive Biotechnologies)

All health care companies by market valueLargest companies in the United KingdomAll stocks A–Z

LivaNova PLC (LIVN): questions and answers

What is LIVN's P/E ratio?

LivaNova PLC trades at 26.7× its last twelve months' earnings and 19.7× next year's expected earnings.

What is LIVN's PEG ratio?

LivaNova PLC's PEG ratio is 0.93 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is LivaNova PLC's market cap?

LivaNova PLC is valued at $5.14B at a share price of $93.35.

Is LIVN overvalued or undervalued?

Against its own history, LIVN is above its usual price: the price is 17% above the $79.78 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is LIVN above its 200-week moving average?

Yes. LIVN is 67.6% above its 200-week average of $55.71. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is LivaNova PLC growing?

Over the last five fiscal years LivaNova PLC's revenue grew 8.2% a year; over ten years revenue grew 16.9% a year.

Cite this page

Funkfolio, “LivaNova PLC (LIVN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/LIVN

Underlying data: Yahoo Finance; company filings with the SEC.